For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Oscar Health Inc’s stock clocked out at $16.75, down -4.39% from its previous closing price of $17.52. In other words, the price has decreased by -$4.39 from its previous closing price. On the day, 6.18 million shares were traded.
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 13, 2025, Downgraded its rating to Equal Weight and sets its target price to $16 from $20 previously.
On December 10, 2024, Jefferies started tracking the stock assigning a Underperform rating and target price of $12.
BofA Securities Downgraded its Neutral to Underperform on November 06, 2024, whereas the target price for the stock was revised from $21 to $13.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when ALESSANDREA QUANE bought 148,280 shares for $17.52 per share.
Robinson Elbert O. Jr. sold 25,000 shares of OSCR for $410,750 on May 12 ’25. The Director now owns 64,512 shares after completing the transaction at $16.43 per share. On May 14 ’25, another insider, ALESSANDREA QUANE, who serves as the Former Officer of the company, bought 300 shares for $17.51 each.
Valuation Measures:
As of this moment, Oscar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.12, and their Forward P/E ratio for the next fiscal year is 16.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 3.19.
Stock Price History:
Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is 22.43%, while the 200-Day Moving Average is calculated to be 5.18%.
Shares Statistics:
A total of 217.98M shares are outstanding, with a floating share count of 179.40M. Insiders hold about 29.56% of the company’s shares, while institutions hold 61.78% stake in the company.
Earnings Estimates
Currently, 4.0 analysts are dedicated to thoroughly evaluating and rating the performance of Oscar Health Inc (OSCR) in the stock market.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.02 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.88 and $0.65 for the fiscal current year, implying an average EPS of $0.77. EPS for the following year is $1.09, with 5.0 analysts recommending between $1.85 and $0.75.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $2.84B. It ranges from a high estimate of $3B to a low estimate of $2.72B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.22BFor the next quarter, 7 analysts are estimating revenue of $2.79B. There is a high estimate of $2.86B for the next quarter, whereas the lowest estimate is $2.69B.
A total of 8 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $11.29B, while the lowest revenue estimate was $11.05B, resulting in an average revenue estimate of $11.24B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $11.13B in the next fiscal year. The high estimate is $12.64B and the low estimate is $9.03B.
